Performance of EUCAST and CLSI approaches for co-amoxiclav susceptibility testing conditions for clinical categorization of a collection ofEscherichia coliisolates with characterized resistance phenotypes

Widespread implementation of EUCAST breakpoints for antibacterial susceptibility testing in Europe

(2015) D Brown et al.   Eurosurveillance

Inhibitor-Resistant TEM- and OXA-1-Producing Escherichia coli Isolates Resistant to Amoxicillin-Clavulanate Are More Clonal and Possess Lower Virulence Gene Content than Susceptible Clinical Isolates

(2014) Jesús Oteo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Reply to Krause et al

(2014) P. R. Solari et al.   CLINICAL INFECTIOUS DISEASES

Is the standard dose of amoxicillin-clavulanic acid sufficient?

(2014) Michiel Haeseker et al.   BMC Pharmacology & Toxicology

Consequences of switching from a fixed 2 : 1 ratio of amoxicillin/clavulanate (CLSI) to a fixed concentration of clavulanate (EUCAST) for susceptibility testing of Escherichia coli

(2013) M. A. Leverstein-van Hall et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Spanish Multicenter Study of the Epidemiology and Mechanisms of Amoxicillin-Clavulanate Resistance in Escherichia coli

(2012) Adriana Ortega et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical breakpoint changes and their impact on surveillance of antimicrobial resistance in Escherichia coli causing bacteraemia

(2012) A.K. van der Bij et al.   CLINICAL MICROBIOLOGY AND INFECTION

 -Lactam/ -Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum  -Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts

(2011) J. Rodriguez-Bano et al.   CLINICAL INFECTIOUS DISEASES

Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011 on antibiotic susceptibility test reporting of Gram-negative bacilli

(2011) M. Hombach et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Impact of restricted amoxicillin/clavulanic acid use on Escherichia coli resistance—antibiotic DU90% profiles with bacterial resistance rates: a visual presentation

(2010) Suzana Mimica Matanovic et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Diversity of Escherichia coli Strains Producing Extended-Spectrum  -Lactamases in Spain: Second Nationwide Study

(2010) M. A. Diaz et al.   JOURNAL OF CLINICAL MICROBIOLOGY